Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
For help with your GLP-1 agonist or therapeutic peptide projects, please inquire and speak to one of our scientists through our Contact Us page or call us at +1 (510) 899-8814
Lixisenatide: First global approval
In this study, the stability of the NPs varied based on the mass ratio of zein to FU, with the 2:1 NP exhibiting the greatest stability, and the release of pterostilbene was slower in pterostilbene-zein/FU (2:1) NPs compared to pterostilbene-zein NPs (Liu et al., 2020)
10.1016/j.neubiorev.2021.09.054 190
Despite significant advances in understanding GLP-1RAs' mechanisms of action and their application in diabetes treatment, several critical knowledge gaps persist
US$ 26.11
US$ 20.44
US$ 29.30
